MARY AHMADIAN: Open Payments
NPI 1952812448 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$825 in 44 payments from 12 companies in 2025. Trend: 2023 $1,068 · 2024 $932 · 2025 $825
Food & beverage: $825
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $349 |
| Madrigal Pharmaceuticals | 5 | $133 |
| PFIZER INC. | 5 | $95 |
| GENZYME CORPORATION | 2 | $53 |
| Janssen Biotech, Inc. | 3 | $51 |
| Ardelyx, Inc. | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Novo Nordisk Inc | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
Products named: RINVOQ, REZDIFFRA, DUPIXENT, VELSIPITY, TREMFYA, CREON, XELJANZ, IBSRELA.
Industry payments across CA — which companies pay providers there.
